Viewing StudyNCT06263153



Ignite Creation Date: 2024-05-06 @ 8:07 PM
Last Modification Date: 2024-10-26 @ 3:21 PM
Study NCT ID: NCT06263153
Status: RECRUITING
Last Update Posted: 2024-07-03
First Post: 2024-02-08

Brief Title: Futibatinib in Combination With Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Cancer Patients Who Are Ineligible for Cisplatin-based Therapy
Sponsor: Yuanquan Yang
Organization: Ohio State University Comprehensive Cancer Center

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-08-01
Start Date Type: ESTIMATED
Primary Completion Date: 2025-12-31
Primary Completion Date Type: ESTIMATED
Completion Date: 2025-12-31
Completion Date Type: ESTIMATED
First Submit Date: 2024-02-08
First Submit QC Date: February 15 2024
Study First Post Date: 2024-02-16
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-09-30
Last Update Post Date: 2024-07-03
Last Update Post Date Type: ACTUAL